Skip to main content
Top
Published in: Italian Journal of Pediatrics 1/2011

Open Access 01-12-2011 | Review

Framework conditions facilitating paediatric clinical research

Authors: Anne-Laure Knellwolf, Stéphane Bauzon, Ornella Della Casa Alberighi, Irja Lutsar, Ernö Bácsy, Deborah Alfarez, Pietro Panei

Published in: Italian Journal of Pediatrics | Issue 1/2011

Login to get access

Abstract

The use of unlicensed and "off-label" medicines in children is widespread. Between 50-80% of the medicines currently administered to children have neither been tested nor authorized for their use in the paediatric population which represents approximately 25% of the whole European population. On 26 January 2007, entered into force the European Regulation of Paediatric Medicines. It aims at the quality of research into medicines for children but without subjecting the paediatric population to unnecessary clinical trial. This article addresses ethical and legal issues arising from the regulation and makes recommendations for the framework conditions facilitating the development of clinical research with children.
Literature
3.
go back to reference Rocchi F, Paolucci P, Ceci A, Rossi P: The European paediatric legislation: benefits and perspectives. Italian J Pediatr. 2010, 36: 56-CrossRef Rocchi F, Paolucci P, Ceci A, Rossi P: The European paediatric legislation: benefits and perspectives. Italian J Pediatr. 2010, 36: 56-CrossRef
4.
5.
go back to reference Welzing L, Harnischmacher U, Weyersberg A, Roth B: Consequences of Directives 2001/20/EC for investigator-initiated trials in the paediatric population-a filed report. Eur J Pediatr. 2007, 166: 1169-1176.CrossRefPubMed Welzing L, Harnischmacher U, Weyersberg A, Roth B: Consequences of Directives 2001/20/EC for investigator-initiated trials in the paediatric population-a filed report. Eur J Pediatr. 2007, 166: 1169-1176.CrossRefPubMed
6.
go back to reference Anderson M, Choonara I: A systematic review of safety and monitoring and drug toxicity in published controlled trials antiepileptic drugs in children over a 10 year period. Arch Dis Child. 2010, 95: 731-738.CrossRefPubMed Anderson M, Choonara I: A systematic review of safety and monitoring and drug toxicity in published controlled trials antiepileptic drugs in children over a 10 year period. Arch Dis Child. 2010, 95: 731-738.CrossRefPubMed
7.
go back to reference Sammons HM, Gray C, Hudson H, Cherrill J, Choonara I: Safety in pediatric clinical trials-a 7 year review. Acta Paediatr. 2008, 97: 474-477.CrossRefPubMed Sammons HM, Gray C, Hudson H, Cherrill J, Choonara I: Safety in pediatric clinical trials-a 7 year review. Acta Paediatr. 2008, 97: 474-477.CrossRefPubMed
8.
go back to reference Ernest TB, Elder DP, Martini LG, Roberts M, Ford JL: Developing paediatric medicines: identifying the needs and recognizing the challenges. J Pharm Pharmacol. 2007, 59: 1043-1055.CrossRefPubMed Ernest TB, Elder DP, Martini LG, Roberts M, Ford JL: Developing paediatric medicines: identifying the needs and recognizing the challenges. J Pharm Pharmacol. 2007, 59: 1043-1055.CrossRefPubMed
9.
10.
go back to reference Schreiner MS: Paediatric Clinical trials: redressing the imbalance. Nat Rev Drug Discov. 2003, 2: 949-961.CrossRefPubMed Schreiner MS: Paediatric Clinical trials: redressing the imbalance. Nat Rev Drug Discov. 2003, 2: 949-961.CrossRefPubMed
11.
go back to reference Ward RM, Kauffman R: Future of Pediatric Therapeutics: Reauthorization of BPCA and PREA. Clin Pharmacol Ther. 2007, 81: 477-479.CrossRefPubMed Ward RM, Kauffman R: Future of Pediatric Therapeutics: Reauthorization of BPCA and PREA. Clin Pharmacol Ther. 2007, 81: 477-479.CrossRefPubMed
12.
go back to reference Boots I, Sukhai RN, Klein RH, Holl RA, Wit JM, Cohen AF, Burggraaf J: Stimulation programs for pediatric drug research - do children really benefit?. Eur J Pediatr. 2007, 166: 849-855.PubMedCentralCrossRefPubMed Boots I, Sukhai RN, Klein RH, Holl RA, Wit JM, Cohen AF, Burggraaf J: Stimulation programs for pediatric drug research - do children really benefit?. Eur J Pediatr. 2007, 166: 849-855.PubMedCentralCrossRefPubMed
14.
go back to reference Code de la Santé Publique of the French Law: Protection des personnes en matière de santé Titre II: Recherches biomédicales, Chapitre VI: Dispositions pénales. 2004, Article L. 1126-1 Code de la Santé Publique of the French Law: Protection des personnes en matière de santé Titre II: Recherches biomédicales, Chapitre VI: Dispositions pénales. 2004, Article L. 1126-1
15.
go back to reference Fennelly N: Legal Interpretation At The European Court Of Justice. 20 Fordham Int'l L.J. 656. 1997 Fennelly N: Legal Interpretation At The European Court Of Justice. 20 Fordham Int'l L.J. 656. 1997
16.
go back to reference Caldwell PHY, Murphy SB, Butow PN, Craig JC: Clinical trial in children. Lancet. 2004, 364: 803-811.CrossRefPubMed Caldwell PHY, Murphy SB, Butow PN, Craig JC: Clinical trial in children. Lancet. 2004, 364: 803-811.CrossRefPubMed
17.
go back to reference Caldwell PHY, Butow PN, Craig JC: Parents' attitudes to children's participation in randomized controlled trials. J Pediatr. 2003, 142: 554-559.CrossRefPubMed Caldwell PHY, Butow PN, Craig JC: Parents' attitudes to children's participation in randomized controlled trials. J Pediatr. 2003, 142: 554-559.CrossRefPubMed
18.
go back to reference Massimo LM, Wiley TJ, Casari EF: From informed consent to shared consent: a developing process in paediatric oncology. Lancet Oncol. 2004, 5: 384-387.CrossRefPubMed Massimo LM, Wiley TJ, Casari EF: From informed consent to shared consent: a developing process in paediatric oncology. Lancet Oncol. 2004, 5: 384-387.CrossRefPubMed
19.
go back to reference Caldwell PHY, Butow PN, Craig JC: Pediatricians' attitudes toward randomized controlled trials involving children. J Pediatr. 2002, 141: 798-803.CrossRefPubMed Caldwell PHY, Butow PN, Craig JC: Pediatricians' attitudes toward randomized controlled trials involving children. J Pediatr. 2002, 141: 798-803.CrossRefPubMed
20.
go back to reference McIntosh N, Bates P, Brykczynska G, Dunstan G, Goldman A, Harvey D, Larcher V, McCrae D, McKinnon A, Patton M, Saunders J, Shelley P: Guidelines for the ethical conduct of medical research involving children. Royal College of Paediatrics and Child Health: Ethics Advisory Committee. Arch Dis Child. 2000, 82: 177-182.CrossRefPubMed McIntosh N, Bates P, Brykczynska G, Dunstan G, Goldman A, Harvey D, Larcher V, McCrae D, McKinnon A, Patton M, Saunders J, Shelley P: Guidelines for the ethical conduct of medical research involving children. Royal College of Paediatrics and Child Health: Ethics Advisory Committee. Arch Dis Child. 2000, 82: 177-182.CrossRefPubMed
21.
go back to reference Sammons H: Ethical issues of clinical trials in children: a European perspective. Arch Dis Child. 2009, 94: 474-477.CrossRefPubMed Sammons H: Ethical issues of clinical trials in children: a European perspective. Arch Dis Child. 2009, 94: 474-477.CrossRefPubMed
23.
go back to reference Cherrill J, Hudson H, Cocking C, Unsworth V, Franck L, Fakis A, McIntyre J, Choonara I: Clinical trials: the viewpoint of children with a chronic illness compared with healthy children. Arch Dis Child. 2010, 95: 229-232.CrossRefPubMed Cherrill J, Hudson H, Cocking C, Unsworth V, Franck L, Fakis A, McIntyre J, Choonara I: Clinical trials: the viewpoint of children with a chronic illness compared with healthy children. Arch Dis Child. 2010, 95: 229-232.CrossRefPubMed
24.
go back to reference Kodish E: Informed consent for pediatric research: is it really possible?. J Pediatr. 2003, 142: 89-90.CrossRefPubMed Kodish E: Informed consent for pediatric research: is it really possible?. J Pediatr. 2003, 142: 89-90.CrossRefPubMed
25.
go back to reference Altavilla A, Giaquinto C, Ceci A: European survey on the ethical and legal frameworks of clinical trials in paediatrics; results and perpectives. J Int Bioéthique. 2008, 19: 17-48. 121-122CrossRefPubMed Altavilla A, Giaquinto C, Ceci A: European survey on the ethical and legal frameworks of clinical trials in paediatrics; results and perpectives. J Int Bioéthique. 2008, 19: 17-48. 121-122CrossRefPubMed
28.
go back to reference Gill D: Ethical principles and operational guidelines for good clinical practice in paediatric research. Recommendations of the ethics working group of Confederation of European Specialists in Paediatrics (CESP). Eur J Pediatr. 2004, 163: 53-57.CrossRefPubMed Gill D: Ethical principles and operational guidelines for good clinical practice in paediatric research. Recommendations of the ethics working group of Confederation of European Specialists in Paediatrics (CESP). Eur J Pediatr. 2004, 163: 53-57.CrossRefPubMed
30.
go back to reference Wendler D, Jenkins T: Children's and their parents' views on facing research risks for the benefit of others. Arch Pediatr Adolesc Med. 2008, 162: 9-14.CrossRefPubMed Wendler D, Jenkins T: Children's and their parents' views on facing research risks for the benefit of others. Arch Pediatr Adolesc Med. 2008, 162: 9-14.CrossRefPubMed
31.
go back to reference Westra AE, Engberts DP, Sukhai RN, Wit JM, de Beaufort ID: Drug development for children: how adequate is the current European ethical guidance?. Arch Dis Child. 2010, 95: 3-6.CrossRefPubMed Westra AE, Engberts DP, Sukhai RN, Wit JM, de Beaufort ID: Drug development for children: how adequate is the current European ethical guidance?. Arch Dis Child. 2010, 95: 3-6.CrossRefPubMed
32.
go back to reference Kurz R, Gill D, Mjones S: Ethical issues in the daily medical care of children. Eur J Pediatr. 2006, 165: 83-86.CrossRefPubMed Kurz R, Gill D, Mjones S: Ethical issues in the daily medical care of children. Eur J Pediatr. 2006, 165: 83-86.CrossRefPubMed
33.
go back to reference World Medical Association: Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects; 59th WMA General Assembly, Seoul, October. 2008 World Medical Association: Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects; 59th WMA General Assembly, Seoul, October. 2008
34.
go back to reference Bertoye PH, Courcier-Duplantier S, Best N, the participants in Round Table N°2, Giens XXI: Adaptation of the application of Good Clinical Practice depending on the features of research projects. Therapie. 2006, 61: 279-285.CrossRefPubMed Bertoye PH, Courcier-Duplantier S, Best N, the participants in Round Table N°2, Giens XXI: Adaptation of the application of Good Clinical Practice depending on the features of research projects. Therapie. 2006, 61: 279-285.CrossRefPubMed
35.
go back to reference Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello B, Hechtman L, Epstein JN, Pelham WE, Abikoff HB, Newcorn JH, Molina BS, Hinshaw SP, Wells KC, Hoza B, Jensen PS, Gibbons RD, Hur K, Stehli A, Davies M, March JS, Conners CK, Caron M, Volkow ND: Effects of stimulant medication on growth rates 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry. 2007, 46: 1015-1027.CrossRefPubMed Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello B, Hechtman L, Epstein JN, Pelham WE, Abikoff HB, Newcorn JH, Molina BS, Hinshaw SP, Wells KC, Hoza B, Jensen PS, Gibbons RD, Hur K, Stehli A, Davies M, March JS, Conners CK, Caron M, Volkow ND: Effects of stimulant medication on growth rates 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry. 2007, 46: 1015-1027.CrossRefPubMed
36.
go back to reference Committee on Drugs, American Academy on Pediatrics: Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics. 1995, 95: 286-294. Committee on Drugs, American Academy on Pediatrics: Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics. 1995, 95: 286-294.
38.
go back to reference Sammons HM, Malhotra J, Choonara I, Sitar DS, Matsui , Rieder MJ: British and Canadian views on the ethics paediatric clinical trials. Eur J Clin Pharm. 2007, 63: 431-436.CrossRef Sammons HM, Malhotra J, Choonara I, Sitar DS, Matsui , Rieder MJ: British and Canadian views on the ethics paediatric clinical trials. Eur J Clin Pharm. 2007, 63: 431-436.CrossRef
39.
go back to reference Ghersi D, Campbell EG, Pentz R, Cox Macpherson C: The future of institutional review boards. Lancet Oncol. 2004, 5: 325-329.CrossRefPubMed Ghersi D, Campbell EG, Pentz R, Cox Macpherson C: The future of institutional review boards. Lancet Oncol. 2004, 5: 325-329.CrossRefPubMed
40.
go back to reference Hoppu K: Paediatric clinical pharmacology at the beginning of a new era. Eur J Clin Pharmacol. 2008, 64: 201-205.CrossRefPubMed Hoppu K: Paediatric clinical pharmacology at the beginning of a new era. Eur J Clin Pharmacol. 2008, 64: 201-205.CrossRefPubMed
43.
go back to reference Christian MC, Goldberg JL, Killen J, Abrams JS, McCabe MS, Mauer JK, Wittes RE: A central institutional review board for multi-institutional trials. N Engl J Med. 2002, 346: 1405-1408.CrossRefPubMed Christian MC, Goldberg JL, Killen J, Abrams JS, McCabe MS, Mauer JK, Wittes RE: A central institutional review board for multi-institutional trials. N Engl J Med. 2002, 346: 1405-1408.CrossRefPubMed
Metadata
Title
Framework conditions facilitating paediatric clinical research
Authors
Anne-Laure Knellwolf
Stéphane Bauzon
Ornella Della Casa Alberighi
Irja Lutsar
Ernö Bácsy
Deborah Alfarez
Pietro Panei
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Italian Journal of Pediatrics / Issue 1/2011
Electronic ISSN: 1824-7288
DOI
https://doi.org/10.1186/1824-7288-37-12

Other articles of this Issue 1/2011

Italian Journal of Pediatrics 1/2011 Go to the issue